Cyclacel Pharmaceuticals (CYCC)
(Delayed Data from NSDQ)
$1.32 USD
-0.13 (-8.97%)
Updated Aug 15, 2024 03:59 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.62 | 0.00% |
Earnings Summary
For their last quarter, Cyclacel Pharmaceuticals (CYCC) reported earnings of -$0.72 per share, beating the Zacks Consensus Estimate of $-0.83 per share. This reflects a positive earnings surprise of 13.25%. Look out for CYCC's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.62 per share, reflecting a year-over-year increase of 91.56%.
Earnings History
Price & Consensus
Zacks News for CYCC
VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Lags Revenue Estimates
CYCC: What are Zacks experts saying now?
Zacks Private Portfolio Services